PLA2G5 Antikörper (AA 21-137) (HRP)
-
- Target Alle PLA2G5 Antikörper anzeigen
- PLA2G5 (phospholipase A2, Group V (PLA2G5))
-
Bindungsspezifität
- AA 21-137
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLA2G5 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Mouse Calcium-dependent phospholipase A2 protein (21-137AA)
- Isotyp
- IgG
- Top Product
- Discover our top product PLA2G5 Primärantikörper
-
anti-phospholipase A2, Group V (PLA2G5) antibody
PLA2G5 Reaktivität: Human WB, IHC (p), IP Wirt: Maus Monoclonal MCL-3G1 unconjugated
anti-phospholipase A2, Group V (PLA2G5) antibodyPLA2G5 Reaktivität: Maus IF Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (C-Term) antibodyPLA2G5 Reaktivität: Human, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (N-Term) antibodyPLA2G5 Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (N-Term) antibodyPLA2G5 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (N-Term) antibodyPLA2G5 Reaktivität: Maus, Ratte, Human, Rind (Kuh), Hund, Pferd, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (Middle Region) antibodyPLA2G5 Reaktivität: Ratte, Human, Rind (Kuh), Hund, Pferd, Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (AA 103-132), (C-Term) antibodyPLA2G5 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PLA2G5 (phospholipase A2, Group V (PLA2G5))
- Andere Bezeichnung
- Pla2g5 (PLA2G5 Produkte)
- Synonyme
- PLA2 antikoerper, sPLA2 antikoerper, FRFB antikoerper, GV-PLA2 antikoerper, PLA2-10 antikoerper, hVPLA(2) antikoerper, phospholipase A2 group V antikoerper, phospholipase A2, group V antikoerper, PLA2G5 antikoerper, Pla2g5 antikoerper
- Hintergrund
-
Background: PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. This isozyme hydrolyzes L-alpha-palmitoyl-2-oleoyl phosphatidylcholine more efficiently than L-alpha-1-palmitoyl-2-arachidonyl phosphatidylcholine, L-alpha-1-palmitoyl-2-arachidonyl phosphatidylethanolamine or L-alpha-1-stearoyl-2-arachidonyl phosphatidylinositol
Aliases: Pla2g5 antibody, Calcium-dependent phospholipase A2 antibody, EC 3.1.1.4 antibody, Group V phospholipase A2 antibody, PLA2-10 antibody, Phosphatidylcholine 2-acylhydrolase 5 antibody
- UniProt
- P97391
- Pathways
- Inositol Metabolic Process
-
